Clarivate Plc (NYSE:CLVT) has a beta value of 1.46 and has seen 0.42 million shares traded in the recent trading session. The company, currently valued at $2.77B, closed the recent trade at $4.00 per share which meant it lost -$0.07 on the day or -1.72% during that session. The CLVT stock price is -94.25% off its 52-week high price of $7.77 and 0.0% above the 52-week low of $4.00. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.38 million shares traded. The 3-month trading volume is 5.30 million shares.
The consensus among analysts is that Clarivate Plc (CLVT) is Buy stock at the moment, with a recommendation rating of 2.36. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.12.
Clarivate Plc (NYSE:CLVT) trade information
Sporting -1.72% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CLVT stock price touched $4.00 or saw a rise of 11.31%. Year-to-date, Clarivate Plc shares have moved -21.26%, while the 5-day performance has seen it change -2.68%. Over the past 30 days, the shares of Clarivate Plc (NYSE:CLVT) have changed -18.53%. Short interest in the company has seen 41.03 million shares shorted with days to cover at 5.7.
Wall Street analysts have a consensus price target for the stock at $12, which means that the shares’ value could jump 66.67% from the levels at last check today. The projected low price target is $11.0 while the price target rests at a high of $20.0. In that case, then, we find that the latest price level in today’s session is -400.0% off the targeted high while a plunge would see the stock gain -175.0% from the levels at last check today.
Clarivate Plc (CLVT) estimates and forecasts
The company’s shares have lost -39.85% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -8.00%.
6 analysts offering their estimates for the company have set an average revenue estimate of 574.03M for the current quarter. 6 have an estimated revenue figure of 593.36M for the next ending quarter. Year-ago sales stood 621.2M and 650.3M respectively for this quarter and the next, and analysts expect sales will shrink by -7.59% for the current quarter and -8.00% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -0.40% over the past 5 years. Earnings growth for 2025 is a modest -11.22% while over the next 5 years, the company’s earnings are expected to increase by 1.98%.
CLVT Dividends
Clarivate Plc is expected to release its next earnings report on 2025-Feb-18 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Clarivate Plc (NYSE:CLVT)’s Major holders
Insiders own 16.27% of the company shares, while shares held by institutions stand at 93.87% with a share float percentage of 112.12%. Investors are also buoyed by the number of investors in a company, with Clarivate Plc having a total of 289.0 institutions that hold shares in the company. The top two institutional holders are LEONARD GREEN & PARTNERS, L.P. with over 116.67 million shares worth more than $663.83 million. As of 2024-06-30, LEONARD GREEN & PARTNERS, L.P. held 17.0167% of shares outstanding.
The other major institutional holder is EXOR N.V., with the holding of over 67.29 million shares as of 2024-06-30. The firm’s total holdings are worth over $382.91 million and represent 9.8155% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Alps Ser Tr-Clarkston Partners Fd and Price (T.Rowe) Mid-Cap Value Fund. As of Dec 31, 2024, the former fund manager holds about 2.55% shares in the company for having 17.61 shares of worth $70.0 million while later fund manager owns 15.91 shares of worth $63.24 million as of Dec 31, 2024, which makes it owner of about 2.30% of company’s outstanding stock.
